{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:57:16Z","timestamp":1790089036510,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Periostin (Postn) is a secreted cell adhesion protein that activates signaling pathways to promote cancer cell survival, angiogenesis, invasion, and metastasis. Interestingly, Postn is frequently overexpressed in numerous human cancers, including breast, lung, colon, pancreatic, and ovarian cancer.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Using transgenic mice expressing the Neu oncogene in the mammary epithelium crossed into Postn-deficient animals, we have assessed the effect of Postn gene deletion on Neu-driven mammary tumorigenesis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Although Postn is exclusively expressed in the stromal fibroblasts of the mammary gland, Postn deletion does not affect mammary gland outgrowth during development or pregnancy. Furthermore, we find that loss of Postn in the mammary epithelium does not alter breast tumor initiation or growth in mouse mammary tumor virus (MMTV)-Neu expressing mice but results in an apocrine-like tumor phenotype. Surprisingly, we find that tumors derived from Postn-null animals express low levels of Notch protein and Hey1 mRNA but increased expression of androgen receptor (AR) and AR target genes. We show that tumor cells derived from wild-type animals do not proliferate when transplanted in a Postn-null environment but that this growth defect is rescued by the overexpression of active Notch or the AR target gene prolactin-induced protein (PIP\/GCDFP-15).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Together our data suggest that loss of Postn in an ErbB2\/Neu\/HER2 overexpression model results in apocrine-like tumors that activate an AR-dependent pathway. This may have important implications for the treatment of breast cancers involving the therapeutic targeting of periostin or Notch signaling.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13058-014-0513-8","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T16:32:28Z","timestamp":1421339548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Loss of periostin\/OSF-2 in ErbB2\/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity"],"prefix":"10.1186","volume":"17","author":[{"given":"Roshan","family":"Sriram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manijeh","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc A","family":"Sabourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10911-006-9009-1","volume":"11","author":"A Badache","year":"2006","unstructured":"Badache A, Goncalves A. The ErbB2 signaling network as a target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2006;11:13\u201325.","journal-title":"J Mammary Gland Biol Neoplasia."},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0014-4827(02)00103-9","volume":"284","author":"DF Stern","year":"2003","unstructured":"Stern DF. ErbBs in mammary development. Exp Cell Res. 2003;284:89\u201398.","journal-title":"Exp Cell Res."},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/bcr327","volume":"3","author":"MA Olayioye","year":"2001","unstructured":"Olayioye MA. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2\/HER-2 and family members. Breast Cancer Res. 2001;3:385\u20139.","journal-title":"Breast Cancer Res."},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","volume":"21","author":"NE Hynes","year":"2009","unstructured":"Hynes NE, MacDonald G. ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol. 2009;21:177\u201384.","journal-title":"Curr Opin Cell Biol."},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cncr.2820741326","volume":"74","author":"EG Mansour","year":"1994","unstructured":"Mansour EG, Ravdin PM, Dressler L. Prognostic factors in early breast carcinoma. Cancer. 1994;74:381\u2013400.","journal-title":"Cancer."},{"key":"513_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.onc.1203272","volume":"19","author":"DL Dankort","year":"2000","unstructured":"Dankort DL, Muller WJ. Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene. 2000;19:1038\u201344.","journal-title":"Oncogene."},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341\u201354.","journal-title":"Nat Rev Cancer."},{"key":"513_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc2127","volume":"7","author":"J Ursini-Siegel","year":"2007","unstructured":"Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer. 2007;7:389\u201397.","journal-title":"Nat Rev Cancer."},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A. 1992;89:10578\u201382.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"513_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-4613-1259-8_4","volume":"83","author":"DL Dankort","year":"1996","unstructured":"Dankort DL, Muller WJ. Transgenic models of breast cancer metastasis. Cancer Treat Res. 1996;83:71\u201388.","journal-title":"Cancer Treat Res."},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/0-306-46832-8_23","volume":"480","author":"PM Siegel","year":"2000","unstructured":"Siegel PM, Dankort DL, Muller WJ. Oncogene mediated signal transduction in transgenic mouse models of human breast cancer. Adv Exp Med Biol. 2000;480:185\u201394.","journal-title":"Adv Exp Med Biol."},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1042\/bj2940271","volume":"294","author":"S Takeshita","year":"1993","unstructured":"Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294:271\u20138.","journal-title":"Biochem J."},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1359\/jbmr.1999.14.7.1239","volume":"14","author":"K Horiuchi","year":"1999","unstructured":"Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239\u201349.","journal-title":"J Bone Miner Res."},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"11131","DOI":"10.1128\/MCB.25.24.11131-11144.2005","volume":"25","author":"H Rios","year":"2005","unstructured":"Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005;25:11131\u201344.","journal-title":"Mol Cell Biol."},{"key":"513_CR15","first-page":"1167","volume":"22","author":"Y Kudo","year":"2007","unstructured":"Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol. 2007;22:1167\u201374.","journal-title":"Histol Histopathol."},{"key":"513_CR16","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1038\/sj.onc.1210009","volume":"26","author":"P Baril","year":"2007","unstructured":"Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T, et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene. 2007;26:2082\u201394.","journal-title":"Oncogene."},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"19700","DOI":"10.1074\/jbc.M601856200","volume":"281","author":"W Yan","year":"2006","unstructured":"Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem. 2006;281:19700\u20138.","journal-title":"J Biol Chem."},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1535-6108(04)00081-9","volume":"5","author":"S Bao","year":"2004","unstructured":"Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt\/PKB pathway. Cancer Cell. 2004;5:329\u201339.","journal-title":"Cancer Cell."},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jss.2008.12.042","volume":"160","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Zhang G, Li J, Tao Q, Tang W. The expression analysis of periostin in human breast cancer. J Surg Res. 2010;160:102\u20136.","journal-title":"J Surg Res."},{"key":"513_CR20","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1128\/MCB.24.9.3992-4003.2004","volume":"24","author":"R Shao","year":"2004","unstructured":"Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol. 2004;24:3992\u20134003.","journal-title":"Mol Cell Biol."},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/jcp.2007.052506","volume":"61","author":"F Puglisi","year":"2008","unstructured":"Puglisi F, Puppin C, Pegolo E, Andreetta C, Pascoletti G, D'Aurizio F, et al. Expression of periostin in human breast cancer. J Clin Pathol. 2008;61:494\u20138.","journal-title":"J Clin Pathol."},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"I Malanchi","year":"2011","unstructured":"Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481:85\u20139.","journal-title":"Nature."},{"key":"513_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15:807\u201317.","journal-title":"Nat Cell Biol."},{"key":"513_CR24","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1038\/onc.2013.274","volume":"33","author":"C Chang","year":"2014","unstructured":"Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;33:3225\u201334.","journal-title":"Oncogene."},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"L15","DOI":"10.1530\/ERC-13-0317","volume":"20","author":"T Takeshita","year":"2013","unstructured":"Takeshita T, Omoto Y, Yamamoto-Ibusuki M, Yamamoto Y, Iwase H. Clinical significance of androgen receptor and its phosphorylated form in breast cancer. Endocr Relat Cancer. 2013;20:L15\u201321.","journal-title":"Endocr Relat Cancer."},{"key":"513_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1210\/me.2012-1107","volume":"26","author":"TE Hickey","year":"2012","unstructured":"Hickey TE, Robinson JL, Carroll JS, Tilley WD. Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol. 2012;26:1252\u201367.","journal-title":"Mol Endocrinol."},{"key":"513_CR27","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/cncr.28092","volume":"119","author":"Q Ren","year":"2013","unstructured":"Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, et al. Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 2013;119:2532\u201340.","journal-title":"Cancer."},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/annonc\/mdq678","volume":"22","author":"S Park","year":"2011","unstructured":"Park S, Koo JS, Kim MS, Park HS, Lee JS, Kim SI, et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011;22:1755\u201362.","journal-title":"Ann Oncol."},{"key":"513_CR29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1177\/000313481207800941","volume":"78","author":"C Arslan","year":"2012","unstructured":"Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, et al. Does androgen receptor have a prognostic role in patients with estrogen\/progesterone-negative and c-erbB-2-positive breast cancer? Am Surg. 2012;78:992\u20139.","journal-title":"Am Surg."},{"key":"513_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1309\/AJCP8AVF8FDPTZLH","volume":"138","author":"LM Sutton","year":"2012","unstructured":"Sutton LM, Cao D, Sarode V, Molberg KH, Torgbe K, Haley B, et al. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma. Am J Clin Pathol. 2012;138:511\u20136.","journal-title":"Am J Clin Pathol."},{"key":"513_CR31","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/emboj\/18.8.2149","volume":"18","author":"PM Siegel","year":"1999","unstructured":"Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu\/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. Embo J. 1999;18:2149\u201364.","journal-title":"Embo J."},{"key":"513_CR32","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.1128\/MCB.14.11.7068","volume":"14","author":"PM Siegel","year":"1994","unstructured":"Siegel PM, Dankort DL, Hardy WR, Muller WJ. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol. 1994;14:7068\u201377.","journal-title":"Mol Cell Biol."},{"key":"513_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10585-005-2908-5","volume":"22","author":"AD Borowsky","year":"2005","unstructured":"Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis. 2005;22:47\u201359.","journal-title":"Clin Exp Metastasis."},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell."},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063\u20136.","journal-title":"Gene Ther."},{"key":"513_CR36","doi-asserted-by":"publisher","first-page":"e1868","DOI":"10.1371\/journal.pone.0001868","volume":"3","author":"S Wagner","year":"2008","unstructured":"Wagner S, Storbeck CJ, Roovers K, Chaar ZY, Kolodziej P, McKay M, et al. FAK\/src-family dependent activation of the Ste20-like kinase SLK is required for microtubule-dependent focal adhesion turnover and cell migration. PLoS One. 2008;3:e1868.","journal-title":"PLoS One."},{"key":"513_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2004.06.025","volume":"6","author":"DE White","year":"2004","unstructured":"White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004;6:159\u201370.","journal-title":"Cancer Cell."},{"key":"513_CR38","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1902\/jop.2008.070624","volume":"79","author":"HF Rios","year":"2008","unstructured":"Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ, et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol. 2008;79:1480\u201390.","journal-title":"J Periodontol."},{"key":"513_CR39","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M110.140202","volume":"286","author":"D Ma","year":"2011","unstructured":"Ma D, Zhang R, Sun Y, Rios HF, Haruyama N, Han X, et al. A novel role of periostin in postnatal tooth formation and mineralization. J Biol Chem. 2011;286:4302\u20139.","journal-title":"J Biol Chem."},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/jcb.20115","volume":"92","author":"J Litvin","year":"2004","unstructured":"Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, et al. Expression and function of periostin-isoforms in bone. J Cell Biochem. 2004;92:1044\u201361.","journal-title":"J Cell Biochem."},{"key":"513_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.107.159517","volume":"102","author":"P Snider","year":"2008","unstructured":"Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res. 2008;102:752\u201360.","journal-title":"Circ Res."},{"key":"513_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00428-011-1151-5","volume":"459","author":"L Morra","year":"2011","unstructured":"Morra L, Moch H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 2011;459:465\u201375.","journal-title":"Virchows Arch."},{"key":"513_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.atherosclerosis.2009.07.046","volume":"208","author":"G Li","year":"2009","unstructured":"Li G, Jin R, Norris RA, Zhang L, Yu S, Wu F, et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis. 2009;208:358\u201365.","journal-title":"Atherosclerosis."},{"key":"513_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.archoralbio.2011.07.010","volume":"57","author":"T Watanabe","year":"2012","unstructured":"Watanabe T, Yasue A, Fujihara S, Tanaka E. PERIOSTIN regulates MMP-2 expression via the alphavbeta3 integrin\/ERK pathway in human periodontal ligament cells. Arch Oral Biol. 2012;57:52\u20139.","journal-title":"Arch Oral Biol."},{"key":"513_CR45","first-page":"181","volume":"28","author":"M Kyutoku","year":"2011","unstructured":"Kyutoku M, Taniyama Y, Katsuragi N, Shimizu H, Kunugiza Y, Iekushi K, et al. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. Int J Mol Med. 2011;28:181\u20136.","journal-title":"Int J Mol Med."},{"key":"513_CR46","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/1535-7163.MCT-11-0046","volume":"10","author":"M Zhu","year":"2011","unstructured":"Zhu M, Saxton RE, Ramos L, Chang DD, Karlan BY, Gasson JC, et al. Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis. Mol Cancer Ther. 2011;10:1500\u20138.","journal-title":"Mol Cancer Ther."},{"key":"513_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12079-010-0090-2","volume":"4","author":"HM Zhou","year":"2010","unstructured":"Zhou HM, Wang J, Elliott C, Wen W, Hamilton DW, Conway SJ. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J Cell Commun Signal. 2010;4:99\u2013107.","journal-title":"J Cell Commun Signal."},{"key":"513_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12079-009-0057-3","volume":"3","author":"L Jackson-Boeters","year":"2009","unstructured":"Jackson-Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal. 2009;3:125\u201333.","journal-title":"J Cell Commun Signal."},{"key":"513_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/bcr1530","volume":"8","author":"A Fantozzi","year":"2006","unstructured":"Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006;8:212.","journal-title":"Breast Cancer Res."},{"key":"513_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1152\/physiolgenomics.00078.2009","volume":"39","author":"TV Tkatchenko","year":"2009","unstructured":"Tkatchenko TV, Moreno-Rodriguez RA, Conway SJ, Molkentin JD, Markwald RR, Tkatchenko AV. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genomics. 2009;39:160\u20138.","journal-title":"Physiol Genomics."},{"key":"513_CR51","doi-asserted-by":"publisher","first-page":"e12234","DOI":"10.1371\/journal.pone.0012234","volume":"5","author":"H Tanabe","year":"2010","unstructured":"Tanabe H, Takayama I, Nishiyama T, Shimazaki M, Kii I, Li M, et al. Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells. PLoS One. 2010;5:e12234.","journal-title":"PLoS One."},{"key":"513_CR52","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.biocel.2011.08.005","volume":"43","author":"MM Wang","year":"2011","unstructured":"Wang MM. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol. 2011;43:1550\u201362.","journal-title":"Int J Biochem Cell Biol."},{"key":"513_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1749-6632.2009.05307.x","volume":"1192","author":"J Tao","year":"2010","unstructured":"Tao J, Chen S, Lee B. Alteration of Notch signaling in skeletal development and disease. Ann N Y Acad Sci. 2010;1192:257\u201368.","journal-title":"Ann N Y Acad Sci."},{"key":"513_CR54","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1038\/sj.onc.1202991","volume":"18","author":"A Dievart","year":"2006","unstructured":"Dievart A, Beaulieu N, Jolicoeur P. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene. 2006;18:5973\u201381.","journal-title":"Oncogene."},{"key":"513_CR55","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1038\/onc.2010.186","volume":"29","author":"H Ling","year":"2010","unstructured":"Ling H, Sylvestre JR, Jolicoeur P. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene. 2010;29:4543\u201354.","journal-title":"Oncogene."},{"key":"513_CR56","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1242\/dev.063610","volume":"138","author":"ER Andersson","year":"2011","unstructured":"Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138:3593\u2013612.","journal-title":"Development."},{"key":"513_CR57","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/onc.2012.341","volume":"32","author":"H Ling","year":"2013","unstructured":"Ling H, Jolicoeur P. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise. Oncogene. 2013;32:3410\u20139.","journal-title":"Oncogene."},{"key":"513_CR58","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","volume":"23","author":"AP Weng","year":"2003","unstructured":"Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC, et al. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol. 2003;23:655\u201364.","journal-title":"Mol Cell Biol."},{"key":"513_CR59","first-page":"1393","volume":"28","author":"S Vranic","year":"2013","unstructured":"Vranic S, Schmitt F, Sapino A, Costa JL, Reddy S, Castro M, et al. Apocrine carcinoma of the breast: a comprehensive review. Histol Histopathol. 2013;28:1393\u2013409.","journal-title":"Histol Histopathol."},{"key":"513_CR60","doi-asserted-by":"publisher","first-page":"R257","DOI":"10.1530\/JME-14-0030","volume":"52","author":"FM Fioretti","year":"2014","unstructured":"Fioretti FM, Sita-Lumsden A, Bevan CL, Brooke GN. Revising the role of the androgen receptor in breast cancer. J Mol Endocrinol. 2014;52:R257\u201365.","journal-title":"J Mol Endocrinol."},{"key":"513_CR61","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jcb.20460","volume":"95","author":"KL Burnstein","year":"2005","unstructured":"Burnstein KL. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. J Cell Biochem. 2005;95:657\u201369.","journal-title":"J Cell Biochem."},{"key":"513_CR62","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1095\/biolreprod.105.040014","volume":"72","author":"NH Ing","year":"2005","unstructured":"Ing NH. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol Reprod. 2005;72:1290\u20136.","journal-title":"Biol Reprod."},{"key":"513_CR63","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1095\/biolreprod.102.004937","volume":"68","author":"OM Tirado","year":"2003","unstructured":"Tirado OM, Martinez ED, Rodriguez OC, Danielsen M, Selva DM, Reventos J, et al. Methoxyacetic acid disregulation of androgen receptor and androgen-binding protein expression in adult rat testis. Biol Reprod. 2003;68:1437\u201346.","journal-title":"Biol Reprod."},{"key":"513_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1677\/jme.0.0210217","volume":"21","author":"Y Myal","year":"1998","unstructured":"Myal Y, Iwasiow B, Cosby H, Yarmill A, Blanchard A, Tsuyuki D, et al. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein\/gross cystic disease fluid protein-15 gene in transgenic mice. J Mol Endocrinol. 1998;21:217\u201323.","journal-title":"J Mol Endocrinol."},{"key":"513_CR65","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1093\/annonc\/12.suppl_2.S115","volume":"12","author":"A Sapino","year":"2001","unstructured":"Sapino A, Papotti M, Righi L, Cassoni P, Chiusa L, Bussolati G. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol. 2001;12:S115\u20137.","journal-title":"Ann Oncol."},{"key":"513_CR66","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/modpathol.3880387","volume":"14","author":"A Sapino","year":"2001","unstructured":"Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol. 2001;14:768\u201376.","journal-title":"Mod Pathol."},{"key":"513_CR67","first-page":"127","volume":"17","author":"A Sapino","year":"2000","unstructured":"Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 2000;17:127\u201337.","journal-title":"Semin Diagn Pathol."},{"key":"513_CR68","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.humpath.2012.10.009","volume":"44","author":"MH Luo","year":"2013","unstructured":"Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, et al. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum Pathol. 2013;44:1241\u201350.","journal-title":"Hum Pathol."},{"key":"513_CR69","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/bcr3232","volume":"14","author":"A Naderi","year":"2012","unstructured":"Naderi A, Meyer M. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer. Breast Cancer Res. 2012;14:R111.","journal-title":"Breast Cancer Res."},{"key":"513_CR70","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/jcp.22966","volume":"227","author":"SK Baniwal","year":"2012","unstructured":"Baniwal SK, Little GH, Chimge NO, Frenkel B. Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation. J Cell Physiol. 2012;227:2276\u201382.","journal-title":"J Cell Physiol."},{"key":"513_CR71","doi-asserted-by":"publisher","first-page":"e62361","DOI":"10.1371\/journal.pone.0062361","volume":"8","author":"SK Baniwal","year":"2013","unstructured":"Baniwal SK, Chimge NO, Jordan VC, Tripathy D, Frenkel B. Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner. PLoS One. 2013;8:e62361.","journal-title":"PLoS One."},{"key":"513_CR72","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1128\/MCB.25.4.1425-1436.2005","volume":"25","author":"B Belandia","year":"2005","unstructured":"Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL, Parker MG. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol. 2005;25:1425\u201336.","journal-title":"Mol Cell Biol."},{"key":"513_CR73","doi-asserted-by":"publisher","first-page":"17796","DOI":"10.1074\/jbc.M110.198655","volume":"286","author":"DN Lavery","year":"2011","unstructured":"Lavery DN, Villaronga MA, Walker MM, Patel A, Belandia B, Bevan CL. Repression of androgen receptor activity by HEYL, a third member of the Hairy\/Enhancer-of-split-related family of Notch effectors. J Biol Chem. 2011;286:17796\u2013808.","journal-title":"J Biol Chem."},{"key":"513_CR74","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/bcr3421","volume":"15","author":"J Lehmann-Che","year":"2013","unstructured":"Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, et al. Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. Breast Cancer Res. 2013;15:R37.","journal-title":"Breast Cancer Res."},{"key":"513_CR75","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1139\/Y09-077","volume":"87","author":"A Blanchard","year":"2009","unstructured":"Blanchard A, Nistor A, Castaneda FE, Martin D, Hicks GG, Amara F, et al. Generation and initial characterization of the prolactin-inducible protein (PIP) null mouse: accompanying global changes in gene expression in the submandibular gland. Can J Physiol Pharmacol. 2009;87:859\u201372.","journal-title":"Can J Physiol Pharmacol."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-014-0513-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0513-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:07:48Z","timestamp":1728922068000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-014-0513-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s13058-014-0513-8","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]},"assertion":[{"value":"25 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}